NCT02412111 A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor Status COMPLETED Phase PHASE3
NCT02399241 Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis Status COMPLETED Phase NA
NCT02398383 Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes Status COMPLETED Phase EARLY_PHASE1
NCT02392234 A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation Status COMPLETED Phase PHASE3
NCT02390219 Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease Status COMPLETED Phase PHASE3
NCT02378454 Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children Status COMPLETED Phase N/A
NCT02372383 Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis Status COMPLETED Phase NA
NCT02368080 Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults Status COMPLETED Phase N/A
NCT02363764 The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients Status COMPLETED Phase N/A
NCT02359357 FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02358798 Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period Status COMPLETED Phase NA
NCT02354859 A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study) Status COMPLETED Phase PHASE2
NCT02347657 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor Status COMPLETED Phase PHASE3
NCT02343445 Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) Status COMPLETED Phase PHASE2
NCT02342964 Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis Status COMPLETED Phase NA